Related Experiment Video
Updated: Aug 14, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Hepatitis C-associated autoimmunity in patients coinfected with HIV
Rainer P Woitas1, Bodo Stoschus, Birgit Terjung
1Department of Internal Medicine I, University of Bonn, 53105 Bonn, Germany. Woitas@uni-bonn.de
Insights
Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) coinfection significantly increases autoimmune antibodies like anti-thyroglobulin and anti-cardiolipin. Autoimmunity is common but rarely shows clinical symptoms in coinfected patients.
Area of Science:
- Immunology
- Virology
- Hepatology
Background:
- Hepatitis C virus (HCV) infection is linked to various extrahepatic conditions.
- The impact of extrahepatic manifestations in patients coinfected with HIV and HCV remains unclear.
Purpose of the Study:
- To prospectively evaluate the frequency of autoimmune manifestations in patients with HIV/HCV coinfection.
- To compare autoimmune profiles between HIV/HCV-coinfected, HIV-mono-infected, and HCV-mono-infected individuals.
Main Methods:
- Prospective assessment of autoimmune manifestations in 98 HIV/HCV-coinfected, 45 HIV-mono-infected, and 78 HCV-mono-infected patients.
- Measurement of diagnostic vasculitis scores, viral loads (HCV and HIV), CD4 cell counts, and specific autoantibodies (thyroid, cardiolipin, non-organ-specific), and cryoglobulins.
Main Results:
- Synergistic effects of HCV and HIV coinfection significantly increased prevalence of anti-thyroglobulin (30.6% vs 15.4% HCV, 8.8% HIV) and anti-cardiolipin antibodies (46% vs 9.0% HCV, 31% HIV).
- Cryoglobulinemia type III was associated with HCV infection (25.6% HCV, 20.4% HIV/HCV) but not HIV infection (4.4%).
- Rheumatoid factor was frequent in HCV (48%) but less so in HIV (4.4%) or HIV/HCV (9.5%) coinfection.
Conclusions:
- HIV coinfection differentially modulates the frequency of HCV-related autoimmunity.
- Autoimmune conditions in coinfected patients are seldom accompanied by overt clinical symptoms.
Background:
Hepatitis C virus (HCV) infection is associated with multiple extrahepatic manifestations. It is unclear to what extent extrahepatic manifestations occur in HIV/HCV coinfection.
Methods:
We prospectively assessed cross-sectional frequencies of autoimmune manifestations in HIV/HCV-coinfected patients (n=98), HIV-mono-infected (n=45) and HCV-mono-infected patients (n=78). Diagnostic vasculitis scores, HCV and HIV loads, CD4 cell counts, thyroid-, cardiolipin-, non-organ-specific tissue antibodies (nuclear, smooth muscle, anti-liver-kidney-microsome, neutrophil-cytoplasmic) and cryoglobulins were determined.
Results:
Synergistic effects of HCV and HIV infection were observed with respect to the prevalence of antibodies against thyroglobulin (HCV infection 15.4%, HIV infection 8.8%, HIV/HCV coinfection 30.6%; P<0.001) and cardiolipin antibodies (HCV infection 9.0%, HIV infection 31%, HIV/HCV coinfection 46%; P<0.001). Cryoglobulinemia type III, was significantly associated with HCV infection (HCV, 25.6%; HIV/HCV, 20.4%) but not with HIV infection (4.4%, P<0.05). Rheumatoid factor was commonly detected in patients with HCV infection (48%), but occurred considerably less frequently in patients with HIV infection (4.4%) or HIV/HCV coinfection (9.5%, P<0.01).
Conclusion:
HIV coinfection appears to differentially modulate the frequency of HCV-related autoimmunity. However, autoimmunity is rarely accompanied by clinical manifestations.
Related Concept Videos
Hepatitis
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Viral Hepatitis I: Introduction
Retrovirus Life Cycles
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

